AFL atrial flutter AH arterial hypertension ANS autonomic nervous system APD action
potential duration ARREST-AF Aggressive Risk Factor Reduction Study for Atrial Fibrillation …

Background The optimal rhythm management strategy for people with non‐paroxysmal
(persistent or long‐standing persistent) atrial fibrilation is currently not well defined …

Abstract Aims To validate the European Heart Rhythm Association (EHRA) symptom
classification in atrial fibrillation (AF) and test whether its discriminative ability could be …

Background: In the CABANA trial (Catheter Ablation vs Antiarrhythmic Drug Therapy for
Atrial Fibrillation), catheter ablation did not significantly reduce the primary end point of …

Background—In patients with paroxysmal atrial fibrillation (AF), catheter ablation maintains
sinus rhythm more effectively than antiarrhythmic drugs (AADs), but its effect on symptoms …

Objectives To systematically review and synthesize the literature on the costs of atrial
fibrillation (AF) with attention to study design and costing methods, geography, and …

Background: Atrial fibrillation (AF) imposes a substantial cost burden on the healthcare
system. Weight and risk factor management (RFM) reduces AF burden and improves the …

Abstract Treatment strategy for atrial fibrillation (AF) is a controversial matter. Catheter
ablation is increasingly being used to treat patients with AF, and recent studies have …

Sleep-disordered breathing (SDB) is a highly prevalent condition, and is associated with
many debilitating chronic diseases. The role of untreated obstructive sleep apnea (OSA) in …

BACKGROUND National Institute for Health and Care Excellence (NICE) clinical guidelines
(CGs) make recommendations across large, complex care pathways for broad groups of …